INSIGHTS ON LIQUID DOSE MANUFACTURING

• Mitigating Risks In Sterile Injectable Manufacturing: How CMOs Can Ensure Product Safety

  Sterile injectable manufacturing carries high risks. CMOs like Afton Scientific use rigorous quality systems, audits, and training to ensure patient safety, compliance, and product integrity.

• MilliporeSigma Bio-Expo Live February 2025: Upstream Bioprocessing

  Review the benefits of implementing a closed and sterile sampling system, such as NovaSeptum®, to improve sampling procedures and meet regulatory expectations.

• 5 Common Bowie-Dick Test Failures And How To Prevent Them

  Bowie-Dick test failures indicate serious sterilization issues. Learn the five most common causes and proven strategies to prevent downtime, compliance risks, and compromised product integrity.

• Key Topics And Trends In Aseptic Filling

  Aseptic filling is vital yet often guided by outdated practices. Discover expert insights on modern technologies, evolving regulations, and data-driven strategies to improve compliance and reduce risk in this critical manufacturing step.

• Isolators For Pharmacy Compounding – Time For Change?

  3/14/2025

  Maintaining a contamination-free environment is crucial in drug compounding. Learn how isolator systems can improve safety, efficiency, and regulatory compliance.

• 0.45 m/s ±20% At Working Position In Closed Sterility Testing Isolators: Requirement Or Convention?

  2/19/2026

  Balance compliance and efficiency in sterility testing. Explore how a risk-based approach to airflow and isolator technology aligns with Annex 1 while optimizing contamination control.

• Generate CHO-K1 GFP-Expressing Cells For Cell Line Development Workflow

  11/7/2025

  Discover a high-efficiency workflow for generating GFP-expressing CHO-K1 clones using automated single-cell dispensing to achieve 93% isolation success and stable expression in under five weeks.

• Ready-To-Use Cartridges: Ensuring Compatibility For GLP-1-Based Drugs

  8/27/2024

  Ready-to-use cartridges for GLP-1 applications offer safe, reliable self-administration. See how they can minimize complexities and better align with the stringent demands of modern manufacturing.

• Mitigating Early Development Risks With Samsung Biologics DEVELOPICK™ Platform

  6/5/2024

  This presentation addresses the critical need for high-throughput, reliable analytical development strategies to support expedited Investigational New Drug (IND) applications.